NYSE · Drug Manufacturers - General

AZN (AZN) Stock

$161.96 -0.10% NYSE: AZN Healthcare

Valuation

MetricValue
Price$161.96
Market Cap$251.18B
P/E Ratio24.78
P/B Ratio5.10
P/S Ratio4.21
EPS (TTM)$6.38
52-Week High$212.71
52-Week Low$145.80
Dividend Yield1.28%

Financials & Margins

MetricValue
ROE21.68%
ROA8.96%
ROCE16.41%
Gross Margin78.23%
Operating Margin23.28%
Net Margin17.02%
Debt/Equity0.64
Current Ratio0.94

Annual Financials (USD)

Metric20212022202320242025
Revenue$37.4B$44.4B$45.8B$54.1B$58.7B
Operating Profit$1.1B$3.8B$8.2B$10.0B$13.7B
Net Profit$112.0M$3.3B$6.0B$7.0B$10.3B
EPS$0.08$2.11$3.81$4.50$6.54
Op Margin2.8%8.5%17.9%18.5%23.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$105.4B$96.5B$101.1B$104.0B$114.1B
Total Liabilities$66.1B$59.4B$62.0B$63.2B$65.4B
Cash$6.3B$6.2B$5.8B$5.5B$5.7B
Borrowings$30.7B$29.1B$28.6B$30.1B$29.7B

Latest News

Panic grips Ionis Pharmaceuticals investors amid bad news spree TheStreet · Jul 12, 2026 AstraZeneca erases billions after sobering reveal TheStreet · Jul 12, 2026 AstraZeneca Updates 2030 Sustainability Goals as AI and Emissions Cuts Take Center Stage MarketBeat · Jul 11, 2026 Is Alnylam Pharmaceuticals (ALNY) Cheap As Rival Trial Failure Shifts ATTR CM Expectations? Simply Wall St. · Jul 11, 2026 Astrazeneca (AZN) Stock Dips While Market Gains: Key Facts Zacks · Jul 10, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$6.0B$9.8B$10.3B$11.9B$14.6B
Investing Cash Flow$-13.3B$-5.5B$-7.8B$-12.6B$-12.7B
Financing Cash Flow$-418.0M$-1.3B$-1.2B$-1.1B$-442.0M
Net Cash Flow$-1.5B$-55.0M$-346.0M$-208.0M$269.0M
Free Cash Flow$3.8B$7.2B$6.6B$7.3B$8.7B

Valuation & Return Ratios

MetricValue
PEG Ratio1.06
EV / EBITDA13.96
FCF Yield3.27%
Quick Ratio0.67
Interest Coverage7.97
Return 1Y2.76%
Return 3Y24.05%
Return 5Y56.84%

Ownership

Insiders Held0.05%
Institutions Held68.33%
Institutions Float Held68.36%
Institutional HolderSharesReport Date
Investor AB51,587,8102026-03-31
Vanguard Capital Management LLC45,040,1422026-03-31
Capital International Investors34,393,0132026-03-31
FMR, LLC29,601,7242026-03-31
Capital World Investors28,264,5802026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ABBV $260.17 +1.46% 74.06 $459.67B 2.63%
AMGN $435.89 +1.40% 27.15 $235.25B 2.29%
BMY $66.86 +0.07% 14.88 $136.58B 3.73%
GILD $148.94 +1.78% -56.96 $184.92B 2.21%
GSKGSK plc $51.58 9.28 $103.73B 3.49%

About AZN

AZN is led by CEO Pascal Claude Roland Soriot, employs 94,300 people, headquartered in Cambridge, GB, publicly traded since 1993.

AZN stock trades at $161.96 with a market capitalization of $251.18B. The stock is valued at a price-to-earnings (P/E) ratio of 24.78, price-to-book of 5.10, price-to-sales of 4.21. Over the past 52 weeks the stock has ranged between $145.80 and $212.71, and currently trades 23.9% below its 52-week high. It pays a dividend yielding 1.28%.

On profitability, AZN generates a return on equity (ROE) of 21.68% — well above the market average, a sign of a high-quality business, return on capital employed of 16.41%, an operating margin of 23.28%, a net profit margin of 17.02%.

In its most recent fiscal year, AZN reported annual revenue of $58.7B, net profit of $10.3B, revenue has compounded at 17.2% a year over the last five years, profit at 26.3% a year. Profit growing faster than revenue points to expanding margins.

The balance sheet shows a debt-to-equity ratio of 0.64, a current ratio of 0.94, total assets of $114.1B, $5.7B in cash and equivalents.

AZN has an average daily trading volume of 2,774,067 shares, a beta of 0.21 (less volatile than the overall market).

Related Healthcare Stocks

LLY Drug Manufacturers - General $1161.39 +0.40% JNJ Drug Manufacturers - General $270.47 +1.74% ABBV Drug Manufacturers - General $260.17 +1.46% MRK Drug Manufacturers - General $149.59 +1.24% UNH Medical - Healthcare Plans $396.10 +1.72% NVS Drug Manufacturers - General $161.48 +6.19% AMGN Drug Manufacturers - General $435.89 +1.40% TMO Medical - Diagnostics & Research $601.51 -2.53% NVO Biotechnology $45.17 -0.35% ABT Medical - Devices $109.49 -0.79% GILD Drug Manufacturers - General $148.94 +1.78% PFE Drug Manufacturers - General $28.49 +0.09%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides